ESMO Helps Hematologists Assess New Cancer Drugs
The European Society for Medical Oncology has released a tool to help hematologists evaluate the magnitude of clinical benefit expected from new blood cancer treatments.
Source: medscape.com
Page 23 - Hematologic Malignancies News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Hematologic Malignancies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Hematologic Malignancies Today - Breaking & Trending Today
Dr Ahmed on Real-World Findings With Brexu-Cel in MCL
Nausheen Ahmed, MD, discusses findings from a real-world subgroup analysis of brexucabtagene autoleucel in patients with relapsed/refractory mantle cell lymphoma.
Source: onclive.com
Innate Pharma Highlights Increased Lacutamab Clinical Activity From Interim Results of Phase 2 TELLOMAK Study With Updated Olsen Criteria
MARSEILLE, France--(BUSINESS WIRE)--Jun 16, 2023--
Source: bakersfield.com
Ziftomenib Displays Early-Phase Efficacy in Relapsed or Refractory AML
Investigators of the phase 1/2 KOMET-001 trial are seeking to address unmet needs in AML with the investigational menin inhibitor ziftomenib.
Source: onclive.com
Innate Pharma SA: Innate Pharma to Present Updated Interim Phase 2 Efficacy Results of Lacutamab in Mycosis Fungoides at the International Conference on Malignant Lymphoma
Efficacy results of lacutamab in Mycosis Fungoides according to updated lymph node classification in the TELLOMAK Phase 2 study in advanced cutaneous T cell lymphomas Innate Pharma SA (Euronext
Source: finanznachrichten.de